Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens

Kimberly Blackwell, Mark D. Pegram, Elizabeth Tan-Chiu, Lee S. Schwartzberg, Michael Arbushites, J. Maltzman, John Forster, S. D. Rubin, Steven H. Stein, Harold J. Burstein

Annals of Oncology · 2009 · 169 citations · 22 references

DOIFull text

Open access

Concepts

References

22